Tumor Models Shanghai 2018 is a conference dedicated to in vivo Tumor models that are driving research forward.
Tumor Models Shanghai 2018 covers topics such as:
- Developing Mouse Tumor Homograft Model Platform (MuPrime) for Immuno-Oncology Drug Discovery
- The State of Play for Preclinical Oncology Modelling in Asia
- Preclinical Anti-Tumor Property of the 2nd Generation Anti-PDL1 MSB2311
- In Vivo Modelling for Testing of a Novel Metabolic Pathway
- Using Data Gained from Preclinical Mouse Models to Better Inform Biomarker and Patient Selection
- Understanding the Biological Effects of Mesenchymal Stem Cells and their Effect on Different Tumor Microenvironments
- Preclinical Development of T-Cell Redirecting Bispecific Antibodies
- Which Problem Should We Fix: The Targets, the Models or Both?
- Preclinical Development of Anti-HGF (Hepatocyte Growth Factor) Antibody
- Challenge and opportunity in animal models for immuno-oncology
